ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,65
-0,88%
Dow Jones
38 196,18
0,77%
DAX
17 896,50
-0,14%
Brent Oil
83,64
0,12%
Bitcoin
59 071,81
1,43%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Ginkgo Bioworks Holdings Inc (DNA)

  7. Ginkgo Bioworks Holdings Inc (DNA) Actualités

DNA Ginkgo Bioworks Holdings Inc

0,8612
0,0191 (2,27%)
Dernière mise à jour : 21:20:34
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Ginkgo Bioworks Holdings Inc DNA NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0191 2,27% 0,8612 21:20:34
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,8781 0,82 0,91 0,8421
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202413:00PRNUSGinkgo Bioworks Announces Date of First Quarter 2024 Results..
29/4/202422:01PRNUSGinkgo Bioworks Announces Nomination of Myrtle Potter and..
16/4/202413:02PRNUSIl Granaio delle Idee and Ginkgo Bioworks Announce Strategic..
11/4/202413:01PRNUSGinkgo Bioworks Announces Acquisition of AgBiome's Platform..
10/4/202413:02PRNUSGinkgo Bioworks and Novo Nordisk Expand Alliance to..
10/4/202413:01PRNUSGinkgo Bioworks Awarded Grant for AI-enabled Forecasting of..
08/4/202413:00PRNUSIdeeLab Joins the Ginkgo Technology Network to Provide..
04/4/202413:01PRNUSGinkgo Bioworks to Host 5th Annual Ferment Conference
03/4/202413:02PRNUSProzomix and Ginkgo Bioworks Collaborate on Next-Gen Enzyme..
02/4/202413:02PRNUSGinkgo Bioworks Acquires Modulus Therapeutics' Cell Therapy..
28/3/202412:02PRNUSGinkgo Bioworks Awarded DARPA Funding to Produce Novel..
27/3/202412:02PRNUSAQUA Cultured Foods Partners with Ginkgo Bioworks to..
26/3/202412:02PRNUSImagindairy and Ginkgo Bioworks Collaborate to Develop and..
12/3/202412:01PRNUSCDC Traveler-based Genomic Surveillance Program to Expand to..
12/3/202412:00GLOBECDC Traveler-based Genomic Surveillance Program to Expand to..
11/3/202415:55EDGAR2Form 144 - Report of proposed sale of securities
08/3/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:27EDGAR2Form 144 - Report of proposed sale of securities
07/3/202416:09EDGAR2Form 144 - Report of proposed sale of securities
06/3/202423:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202416:04EDGAR2Form 144 - Report of proposed sale of securities
05/3/202418:42EDGAR2Form 144 - Report of proposed sale of securities
05/3/202401:43EDGAR2Form 144 - Report of proposed sale of securities
04/3/202418:28EDGAR2Form 144 - Report of proposed sale of securities
01/3/202420:18EDGAR2Form 144 - Report of proposed sale of securities
29/2/202423:03EDGAR2Form 8-K - Current report
29/2/202423:01PRNUSGinkgo Bioworks Reports Fourth Quarter and Full Year 2023..
29/2/202418:46EDGAR2Form 144 - Report of proposed sale of securities
28/2/202417:22EDGAR2Form 144 - Report of proposed sale of securities
28/2/202413:12BWbit.bio Announced as Inaugural Partner of Ginkgo Bioworks’..
28/2/202413:03PRNUSGinkgo Bioworks Provides Compensation Information Related to..
28/2/202413:02PRNUSGinkgo Bioworks Acquires Patch Biosciences, Expanding Suite..
28/2/202413:01PRNUSGinkgo Technology Network Launches, Providing an Integrated..
27/2/202415:59EDGAR2Form 144 - Report of proposed sale of securities
27/2/202415:00PRNUSGinkgo Biosecurity Launches Doha-Based Pathogen Monitoring..
27/2/202413:05PRNUSGinkgo Bioworks Announces Participation in the 44th Annual..
26/2/202417:01EDGAR2Form 144 - Report of proposed sale of securities
23/2/202416:07EDGAR2Form 144 - Report of proposed sale of securities
22/2/202416:18EDGAR2Form 144 - Report of proposed sale of securities
22/2/202413:00PRNUSGinkgo Bioworks Announces Date of Fourth Quarter and Full..
21/2/202416:42EDGAR2Form 144 - Report of proposed sale of securities
20/2/202417:42EDGAR2Form 144 - Report of proposed sale of securities
16/2/202415:51EDGAR2Form 144 - Report of proposed sale of securities
15/2/202416:06EDGAR2Form 144 - Report of proposed sale of securities
15/2/202413:02PRNUSGinkgo Bioworks and SaponiQx Awarded MCDC Contract to..
14/2/202423:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202423:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202423:05EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202423:03EDGAR2Form SC 13D/A - General statement of acquisition of..

Dernières Valeurs Consultées

NYSE
DNA
Ginkgo Bioworks
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés